Form 4 for TMO Thermo Fisher Scientific
Accepted 2025-09-09 00:00:00 ET · period of report 2025-09-05 · accession 0000097745-25-000131 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-09-09 | 2025-09-05 | TMO | CASPER MARC N | COB, CEO, Dir | S - Sale+OE | $500.50 | -400 | 114.0K | -0.3% | -$200.2K |
| D | 2025-09-09 | 2025-09-05 | TMO | CASPER MARC N | COB, CEO, Dir | M - OptEx | $253.99 | +400 | 114.2K | +0.4% | +$101.6K |
| D | 2025-09-09 | 2025-09-05 | TMO | CASPER MARC N | COB, CEO, Dir | M - OptEx | $0.00 | -400 | 24.4K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-05 | S | D | 100 | $501.01 | 113,762.29 | D | — | — | |
| 2 | Common | Common Stock | 2025-09-05 | S | D | 100 | $501.00 | 113,862.29 | D | — | — | |
| 3 | Common | Common Stock | 2025-09-05 | M | A | 400 | $253.99 | 114,162.29 | D | — | — | |
| 4 | Common | Common Stock | 2025-09-05 | S | D | 200 | $500.00 | 113,962.29 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-09-05 | M | D | 400 | $0.00 | 24,354 | D | $253.99 · — to 2026-02-26 | 400 Common Stock | (F4) The option vested in four equal installments on February 26, 2020, 2021, 2022, and 2023. |